International Journal of Clinical and Health Psychology (2) Interamerican Journal of Psychology (1) Psicothema (1) Papeles del Psicólogo (1) HAL-SHS : sciences de l'éducation (1) Anales de Psicología (1) HAL-SHS : linguistique (1) International Journal of Psychology and Psychological Therapy (1) Investigación y Ciencia (1) Psychosocial Intervention (1) Salud Pública de México (1) Universitas Psychologica (1) Kernos (1) Avances en Psicología Latinoamericana (1) Revista Latinoamericana de Psicología (1) HAL-SHS : histoire de l'art (1) Anuario de Psicología (1)

Mot-clé

nourisson (1) mutation (1) modèle (1) danger (1) Europe (1) maladie (1) point (1) enfant (1) procès (1) taux (1) survie (1) Europe (1) Treatment (1) Inhibitors (1) Cases (1) Protein-tyrosine kinase (1) Ci (Chinese poetry) (1) Trials (1) Survival (1) Prognosis (1) Poor (1) Patients (1) Neuroblastoma (1) Human beings (1) Lymphomas (1) Impact (1) Gene amplification (1) Example (1) Europe (1) Clinical trials (1)

Mot-clé

Teenagers (10) Psychology (10) Psicología (10) Estudio (8) Adolescentes (8) Self-esteem (6) Families (6) Equations (5) Datos (5) Ecuaciones (5) Familias (5) Violence (4) Students (4) Mediation (4) Human behavior (4) Mediación (4) Autoestima (4) Estudiantes (4) Conducta (4) Buildings, structures, etc (3) Buildings (3) Assaying (3) Textbooks (3) Textbooks (3) Grammarians (3) Symptoms (3) Speeches, addresses, etc (3) Scholars (3) Physics (3) Perspective (3)

Documents écrit par I. Jiménez (1) | parle de I. Jiménez (18)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

Articles

A. Bellini et al. (20 oct. 2021)

Articles

In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated through activating point mutations or genomic amplification. We studied ALK genetic alterations in high-risk (HR) patients on the HR-NBL1/SIOPEN trial to determine their frequency, correlation with clinical param...